MIRA Pharmaceuticals, Inc.
MIRA Pharmaceuticals, Inc. (MIRA) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · MIRA · as of Jun 9, 2026
Key Statistics
Explore MIRA Pharmaceuticals, Inc. Data
mira stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 100.0%
Competitors & Peers
mira competitorsMIRA
ANTX
APUS
IGC
MLSS
MODDStock Performance
Full HistoryAbout MIRA Pharmaceuticals, Inc.
MIRA Pharmaceuticals, Inc. operates as a biopharmaceutical enterprise currently in the clinical development phase. Its main objective involves the creation and market introduction of a novel synthetic…
what is mira pharmaceuticals, inc. · mira stock overview · mira pharmaceuticals, inc. company profile · who is mira pharmaceuticals, inc. ceo · mira NASDAQ · mira pharmaceuticals, inc. headquarters · mira pharmaceuticals, inc. business segments
About Stock Overview & Key Data
MIRA Pharmaceuticals, Inc. (MIRA) is a Healthcare company in the Drug Manufacturers - General industry, listed on NASDAQ since Aug 14, 2023. As of the latest trading session, MIRA stock price is $1.00, with a market capitalization of $42.0M. The stock has returned -22.48% over the past 12 months and -33.77% year-to-date.
According to 2 Wall Street analysts, the consensus rating for MIRA Pharmaceuticals, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, MIRA Pharmaceuticals, Inc. reported revenue of — and net income of -$10.4M. For detailed data — including MIRA Pharmaceuticals, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, MIRA Pharmaceuticals, Inc. (MIRA) stock price is $1.00. The stock is traded on NASDAQ under the ticker symbol MIRA. The 52-week range is $0.90 – $2.45.